| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
(From the Cancer Research and Cancer Control Unit of the Department of Surgery and the Departments of Medicine and Biochemistry, Tufts College Medical School, Boston 11, the Division of Clinical Research of the Jewish Memorial Hospital, Roxbury, and the Cancer Research Laboratories of the Holy Ghost Hospital, Cambridge, Massachusetts)
Serum alkaline phosphatase from subjects with and without cancer was inhibited by zinc sulfate (1 x 10-5 M) to the same extent. These data contrast with those of Roche in which the normal group showed no change or an activation of serum alkaline phosphatase by zine ion.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |